Emerging frontiers in androgen receptor research for prostate Cancer: insights from the 2nd international androgen receptor Symposium.
Saved in:
| Title: | Emerging frontiers in androgen receptor research for prostate Cancer: insights from the 2nd international androgen receptor Symposium. |
|---|---|
| Authors: | Israel JS; Department of Urology, Faculty of Medicine, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany., Marcelin LM; Department of Urology, Faculty of Medicine, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany., Thomas C; Department of Urology, Faculty of Medicine, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany., Szczyrbová E; Department of Clinical and Molecular Pathology, Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacký University and University Hospital, Olomouc, 779 00, Czech Republic., Fuessel S; Department of Urology, Faculty of Medicine, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.; German Cancer Consortium (DKTK), Partner Site Dresden and German Cancer Research Center (DKFZ), Heidelberg, Germany., Puhr M; Department of Urology, Medical University of Innsbruck, Innsbruck, Austria., Linxweiler J; Department of Urology, Saarland University, Homburg/Saar, Germany., Yalala S; Department of Biochemistry and Developmental Biology, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Zwart WT; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Baniahmad A; Institute of Human Genetics, Jena University Hospital, Friedrich Schiller University, Jena, Germany., van Goubergen J; Department of Urology, Medical University of Innsbruck, Innsbruck, Austria., Itkonen HM; Department of Biochemistry and Developmental Biology, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Sharp A; Institute of Cancer Research, Sutton, Surrey, UK., O'Neill E; MRC Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, UK., Pretze M; Institut für Radiopharmazie, Helmholtz-Zentrum Dresden-Rossendorf, Bautzner Landstraße 400, D-01328, Dresden, Germany., Miederer M; Department of Translational Imaging in Oncology, National Center for Tumor Diseases (NCT/UCC) Dresden: Faculty of Medicine and University Hospital Carl Gustav Carus, University of Technology Dresden (TUD), German Cancer Research Center (DKFZ) Heidelberg, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany., Erb HHH; Department of Urology, Faculty of Medicine, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany. holger.erb@uniklinikum-dresden.de.; Institute of Human Genetics, Jena University Hospital, Friedrich Schiller University, Jena, Germany. holger.erb@uniklinikum-dresden.de.; Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden, Fetscherstraße 74, 01307, Dresden, Germany. holger.erb@uniklinikum-dresden.de. |
| Source: | Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2024 Jul 17; Vol. 43 (1), pp. 194. Date of Electronic Publication: 2024 Jul 17. |
| Publication Type: | Conference Proceedings |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 8308647 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-9966 (Electronic) Linking ISSN: 03929078 NLM ISO Abbreviation: J Exp Clin Cancer Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1756-9966 |
|---|---|
| DOI: | 10.1186/s13046-024-03125-5 |
